Chronic kidney disease and outcomes in hospitalized sickle cell disease patients: A National Inpatient Sample analysis

Abstract

ObjectivesTo examine the association between chronic kidney disease (CKD) and outcomes in sickle cell disease (SCD) patients.MethodsPatients ≥18 years with SCD in the National Inpatient Sample database between 2016 and 2018 were identified using ICD‐10‐CM diagnosis codes. A 1:1 propensity‐score matched analysis was performed to compare in‐hospital outcomes of patients with and without CKD.ResultsOf the 366 240 SCD admissions, 19 365 (5.3%) had CKD. The CKD group had higher odds of in‐hospital mortality (odds ratio [OR] 2.59, 95% confidence interval [CI]: 1.63–4.12, p = <.01), blood transfusion (OR 1.67, 95% CI: 1.47–1.90, p < .01), mechanical ventilation (OR 2.20, 95% CI: 1.56–3.12, p = <.01), sepsis (OR 1.75, 95% CI: 1.46–2.10, p < .01), incurred higher costs ($53 255 vs. $47 294, p < .001), but had lower odds of acute chest syndrome (OR 0.71, 95% CI: 0.54–0.95, p = 0.02) and pulmonary embolism (OR 0.45, 95% CI: 0.31–0.67, p < .01).ConclusionsCKD was associated with higher mortality, higher costs, blood transfusion, sepsis, and mechanical ventilation in SCD patients. Further studies are needed to explore the reasons for the reduced odds of pulmonary embolism and acute chest syndrome.